Kenneth Fernandes
- Oncology top 5%
- Cancer-related Molecular Pathways 15
- Biotechnology top 2%
- Cancer Research and Treatments 5
- Molecular Biology top 5%
- Ubiquitin and proteasome pathways 6
- RNA modifications and cancer 5
- Muscle Physiology and Disorders 4
- Epigenetics and DNA Methylation 4
- Cancer Research top 10%
- Cancer, Lipids, and Metabolism 4
-
- Cardiomyopathy and Myosin Studies 4
Kenneth Fernandes
25 papers receiving 2.2k citations
Hit Papers
Peers
Comparison fields: 5 of 87
- Oncology 931
- Biotechnology 240
- Molecular Biology 1.6k
- Pediatrics, Perinatology and Child Health 417
- Cancer Research 283
Countries citing papers authored by Kenneth Fernandes
This map shows the geographic impact of Kenneth Fernandes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth Fernandes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth Fernandes more than expected).
Fields of papers citing papers by Kenneth Fernandes
This network shows the impact of papers produced by Kenneth Fernandes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth Fernandes. The network helps show where Kenneth Fernandes may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kenneth Fernandes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 12 | |
| 2 | 2018 | 21 | |
| 3 | 2016 | 50 | |
| 4 | 2012 | 31 | |
| 5 | 2012 | 12 | |
| 6 | 2012 | 18 | |
| 7 | 2011 | 48 | |
| 8 | 2011 | 85 | |
| 9 | 2010 | 105 | |
| 10 | 2010 | 99 | |
| 11 | 2006 | 18 | |
| 12 | p53 isoforms can regulate p53 transcriptional activitybreakdown → | 2005 | 631 |
| 13 | 2003 | 96 | |
| 14 | 2002 | 93 | |
| 15 | Epigenetic change in IGF2R is associated with fetal overgrowth after sheep embryo culturebreakdown → | 2001 | 634 |
| 16 | 1997 | 42 | |
| 17 | 1995 | 8 | |
| 18 | 1995 | 27 | |
| 19 | 1993 | 26 | |
| 20 | 1991 | 103 |
About Kenneth Fernandes
Kenneth Fernandes is a scholar working on Oncology, Biotechnology and Cancer Research, having authored 26 papers that have together received 2.3k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (15 papers), Ubiquitin and proteasome pathways (6 papers), Cancer Research and Treatments (5 papers), RNA modifications and cancer (5 papers), Muscle Physiology and Disorders (4 papers), Epigenetics and DNA Methylation (4 papers), Cancer, Lipids, and Metabolism (4 papers) and Cardiomyopathy and Myosin Studies (4 papers). The work is most often cited by research in Oncology (931 citations), Biotechnology (240 citations) and Molecular Biology (1.6k citations). Kenneth Fernandes has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Jean‐Christophe Bourdon, David P. Lane, Alexandra Diot, Mark K. Saville, Geng Liu, Dimitris P. Xirodimas, Lorraine Young, C. Carolan, John J. Robinson and Carlos G. Gutiérrez. Their work appears in journals such as Nature Genetics, Genes & Development and The Journal of Cell Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.